AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window

J Appl Lab Med. 2019 Jan;3(4):743-746. doi: 10.1373/jalm.2018.027391.

Authors

Mark J Biagi¹, David A Butler¹, Eric Wenzler²

Affiliations

¹ College of Pharmacy, University of Illinois at Chicago, Chicago, IL.
² College of Pharmacy, University of Illinois at Chicago, Chicago, IL. wenzler@uic.edu.

PMID: 31639746
DOI: 10.1373/jalm.2018.027391

No abstract available

MeSH terms

Anti-Bacterial Agents / pharmacokinetics
Anti-Bacterial Agents / therapeutic use*
Area Under Curve
Computer Simulation
Consensus
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Monitoring / methods*
Drug Monitoring / standards
Humans
Microbial Sensitivity Tests
Models, Biological
Monte Carlo Method
Practice Guidelines as Topic
Staphylococcal Infections / blood
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / microbiology
Therapeutic Index, Drug*
Vancomycin / pharmacokinetics
Vancomycin / therapeutic use*

Substances

Anti-Bacterial Agents
Vancomycin